Setting and scaling up a SARS-CoV-2 RT-qPCR testing platform webinar

Video

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, can only be effectively countered by a combination strategy of quarantining/social distancing and widespread PCR testing for the presence of viral RNA. The gold standard in Belgium is the use of a nasopharyngeal swab, taken by a healthcare professional, and transported to the test lab in a medium that typically keeps the virus alive. As an ISO17025 accredited lab for RT-qPCR services, Biogazelle had the unique skills set and expertise for RT-qPCR quantification of RNA to develop a robust, sensitive, and high-throughput test for SARS-CoV-2 in 10 days. Crucially important was the usage of reagents, consumables, and instruments that allow (semi-)automation and business continuity despite worldwide shortage.

In this webinar, co-organized and hosted by Tecan, Biogazelle co-founder and CSO Prof. Jo Vandesompele, outlined how we have set up and validated the workflow and how we are further improving it for cost-efficiency and performance.

Key Themes:

  • Biogazelle unique skills and expertise in RT-qPCR quantification
  • Belgium strategy in SARS-CoV-2 RT-qPCR testing
  • Advanced RT-qPCR quantification data analysis and data interpretation
  • Best practices and troubleshooting tips for data analysis
  • Advantages of automating the workflow from sample prep, RNA extraction to RT-qPCR

To watch the webinar, read a transcript and download the webinar slides, please fill out the form below:

Subscribe to email updates